首页> 外文期刊>Scandinavian journal of urology >The value of tumour weight as a predictive factor for recurrence and progression in non-muscle invasive bladder cancer
【24h】

The value of tumour weight as a predictive factor for recurrence and progression in non-muscle invasive bladder cancer

机译:肿瘤重量的价值作为非肌肉侵袭性膀胱癌复发和进展的预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To further assess the influence of the weight after TURBT as a predictive factor for recurrence and progression in NMIBC. Materials and methods: A cohort of patients with a first episode of NMIBC between 1999 and 2016 was analysed retrospectively. We studied the correlation between the tumour's size and weight, the time-dependent ROC curves for the optimal weight value for the prediction of recurrence and progression and their association with the risk of recurrence and progression at one and five years. Results: We analysed 470 patients who met inclusion criteria. Median (IQR) follow-up time was four years (2.2-6.7), 227 (48.3%) patients had a recurrence and 46 (9.8%) progressed. Median (IQR) weight after resection was 2 g (0.8-6) and its correlation with size was 0.56. The optimal value for the prediction of recurrence was 4 g. The RFS at one and five years with a weight <4 g was 77.7% and 53.5%, respectively, compared to 57.8% and 34.7% with higher weight (p < .001). PFS at one and five years was 98% and 92.7% for a weight 4 g, respectively (p = .02). On multivariate analysis, a higher weight was associated with an increased risk of recurrence: HR [95%:CI] = 1.52[1.05-1.86], and progression: HR[95%:CI] = 1.87[1.01-3.47] (p < .05). Conclusion: The weight of the specimen obtained after TURBT is a predictive factor of both recurrence and progression in NMIBC that may be more accurate than tumour size and easily and objectively measured. An increase of 52% and 87% in the risk of recurrence and progression, respectively, was found in tumours weighing more than 4 g.
机译:目的:进一步评估Turbt后重量的影响是NMIBC中复发和进展的预测因素。材料和方法:回顾性地分析了1999年至2016年间NMIBC第一集的患者队列。我们研究了肿瘤大小和重量之间的相关性,时间依赖性的ROC曲线对于预测复发和进展的最佳重量值及其与一到五年复发和进展的危险。结果:我们分析了470名符合纳入标准的患者。中位数(IQR)随访时间为四年(2.2-6.7),227名(48.3%)患者复发,46名(9.8%)进展。切除后的中位数(IQR)重量为2g(0.8-6),其与大小的相关性为0.56。预测复发预测的最佳值为4克。重量<4克的射频分别为77.7%和53.5%,而重量较高(P <0.001)。 PFS在一到五年中分别为98%和92.7%,分别为4克(p = .02)。在多变量分析中,重量较高与复发风险增加有关:HR [95%:Ci] = 1.52 [1.05-1.86]和进展:HR [95%:Ci] = 1.87 [1.01-3.47](p <.05)。结论:在TurBT后获得的标本的重量是NMIBC中复发和进展的预测因素,其可能比肿瘤大小和容易和客观地测量更准确。在重量超过4克的肿瘤中,分别增加了52%和87%,分别存在于重量和进展的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号